Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin

  • rijnstate van Luin*
  • , radboud Brouwer
  • , Andre van der Ven
  • , Wiel de Lange
  • , Ron H N van Schaik
  • , David M Burger
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)742-4
Number of pages3
JournalAIDS (London, England)
Volume23
Issue number6
DOIs
Publication statusPublished - 27 Mar 2009
Externally publishedYes

Keywords

  • AIDS-Related Opportunistic Infections/drug therapy
  • Alkynes
  • Anti-HIV Agents/adverse effects
  • Antibiotics, Antitubercular/therapeutic use
  • Benzoxazines/adverse effects
  • Cyclopropanes
  • Drug Interactions
  • Humans
  • Male
  • Middle Aged
  • Rifampin/therapeutic use
  • Tuberculosis/drug therapy

Cite this